EUVIMEDEUVIMED entdecken
Crossref

Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer

Qi Zhang, Chenying Yang, Zhijian Ma, Liangwen Ye, Yunfeng Wu, Caiyun Zhong iD, Ye Shi, Mingming Zhu

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Qi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Isothiocyanates, Stomach Neoplasms, B7-H1 Antigen, Sulfoxides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province "The 14th Five-year Plan" Key Discipline-Public Health and Preventive Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulforaphane (SFN) exerts anticancer effect on various cancers including gastric cancer. However, the regulatory effect of SFN on programmed death‐ligand 1 (PD‐L1) and checkpoint blockade therapy in gastric cancer have not been elucidated. Here we demonstrated that SFN suppressed gastric cancer cell growth both in vitro and in vivo study. SFN upregulated PD‐L1 expression through activating ΔNP63α in gastric cancer cells. Further, we found that SFN impaired the anticancer effect of anti‐PD‐L1 monoclonal antibody (α‐PD‐L1 mab) on gastric cancer cells. These results uncover a novel PD‐L1 regulatory mechanism and the double‐edged role of SFN in gastric cancer intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsothiocyanatesStomach NeoplasmsB7-H1 AntigenSulfoxidesImmune Checkpoint InhibitorsTranscription FactorsHumansAnimalsMiceCell Line, TumorTumor Suppressor ProteinsCell ProliferationGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysMice, Nude

Stichwörter der Autor:innen

PD‐L1gastric cancerimmune checkpoint blockadesulforaphaneΔNP63α

Substanzen

IsothiocyanatessulforaphaneB7-H1 AntigenSulfoxidesCD274 protein, humanImmune Checkpoint InhibitorsTranscription FactorsTP63 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Yinzhou Center for Disease Control and Prevention, Ningbo, China.
  • Department of Nutrition, School of Acupuncture and Tuina, Nanjing University of Chinese Medicine, Nanjing, China.
  • The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Nutrition and Food Safety, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Department of Thoracic Surgery, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.

ORCID-Profile: Caiyun Zhong

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province "The 14th Five-year Plan" Key Discipline-Public Health and Preventive Medicine

Zitieren

APA

Zhang, Q., Yang, C., Ma, Z., Ye, L., Wu, Y., Zhong, C., Shi, Y., & Zhu, M. (2024). Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23749

Vancouver

Zhang Q, Yang C, Ma Z, Ye L, Wu Y, Zhong C, et al. Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23749

BibTeX
@article{Zhang2024,
  author = {Zhang, Qi and Yang, Chenying and Ma, Zhijian and Ye, Liangwen and Wu, Yunfeng and Zhong, Caiyun and Shi, Ye and Zhu, Mingming},
  title = {Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23749}
}
Kostenlos starten →